.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Argus Health
US Army
McKesson
QuintilesIMS
Johnson and Johnson
Accenture
Chubb
Harvard Business School
Merck

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070085

« Back to Dashboard
NDA 070085 describes METHYLDOPA, which is a drug marketed by Sandoz, Watson Labs, Teva, Duramed Pharms Barr, Pliva, Parke Davis, Par Pharm, Ivax Sub Teva Pharms, Purepac Pharm, Halsey, Sun Pharm Inds, Superpharm, Accord Hlthcare, Mylan, Roxane, Dava Pharms Inc, Marsam Pharms Llc, Smith And Nephew, Hospira, Abraxis Pharm, Teva Parenteral, Luitpold, and Baxter Hlthcare, and is included in ninety-nine NDAs. It is available from ten suppliers. Additional details are available on the METHYLDOPA profile page.

The generic ingredient in METHYLDOPA is methyldopate hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyldopate hydrochloride profile page.

Summary for NDA: 070085

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 070085

Mechanism of ActionAdrenergic alpha2-Agonists

Suppliers and Packaging for NDA: 070085

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHYLDOPA
methyldopa
TABLET;ORAL 070085 ANDA Accord Healthcare Inc. 16729-031 16729-031-01 100 TABLET, FILM COATED in 1 BOTTLE (16729-031-01)
METHYLDOPA
methyldopa
TABLET;ORAL 070085 ANDA Accord Healthcare Inc. 16729-031 16729-031-16 500 TABLET, FILM COATED in 1 BOTTLE (16729-031-16)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Oct 15, 1985TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Harvard Business School
QuintilesIMS
Dow
Johnson and Johnson
Moodys
UBS
Novartis
Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot